Dark Light
, , ,

Psychopharmacology – A Masters Class 2021 (CME VIDEOS)

Date of Original Release: May 15, 2021
Estimated Time to Complete: 14.00 hours



Learning Objectives
Upon completion of this activity, participants will be better able to apply:
– Evaluate the effects of neurotransmitters and genes on psychotropic drug treatment
– Study the interface between neurology and psychiatry
– Describe the pharmacologic treatment of schizophrenia with particular reference to the prodromal period and first episode
– Outline the emerging theories and treatments of bipolar disorder, depression, treatment resistant depression, bipolar depression, stress and anxiety disorder
– Discuss the role of psychotropic medications in women’s mental health with an emphasis on PMS, pregnancy, nursing, and the postpartum period
– Review the appropriate use of medications in the treatment of sleep disorders
– Access psychopharmacologic treatment of eating disorders
– Summarize the interface between medicine and psychiatric disorders with an emphasis on cardiovascular disease and cancer
– Review the appropriate use of stimulants in the treatment of attention and ADHD disorders as well as their use as an adjunct to antidepressant treatment
– Identify psychopharmacologic treatment for the borderline personality disorder
– Explain the role of psychopharmacology in the treatment of substance use disorders with particular emphasis on alcohol, opiates, and cannabis
– Recognize when to utilize ECT and TMS for the treatment of depression
– Discuss standard psychopharmacologic treatments that have now been proven to be ineffective
– Give examples of the latest advances and problems associated with treatment approaches in the child, adolescent and geriatric populations

Neurobiology for the Practicing Clinician – Including Ketamine, Cannabinoids, Inflammation, and Hormones
Carl Salzman, MD
Neuropsychiatry – Interface Between Neurological and Psychiatric Disorders
Martin A. Samuels, MD
The Interface of Medical and Psychiatric Disorders – Focus on Cancer and Heart Disease
Charles B. Nemeroff, MD, PhD
Pharmacological Treatment of Schizophrenia, Prodrome, First Episode, Relapse, and Recovery
Matcheri S. Keshavan, MD
Panel Discussion
Moderator – Carl Salzman, MD
Panel – Drs. Samuels, Nemeroff, and Keshavan
Latest Advances and Current Treatment of Bipolar Mania and Bipolar Depression
Ross J. Baldessarini, MD DSc (hon)
Advances in Treatment for Refractory Depression
Alan F. Schatzberg, MD
The Latest Tricks of the Trade – What to Do When Nothing Works in the Treatment of Resistant Psychiatric Disorders
Stephan M. Stahl, MD, PhD, DSc (hon)
Panel Discussion
Moderator – Carl Salzman, MD
Panel – Drs. Baldessarini, Schatzberg, and Stahl
Anxiety – Treat the Symptoms or Treat the Disorder When First Line Therapies Fail
Stephan M. Stahl, MD, PhD, DSc (hon)

Evaluation and Pharmacological and CBT Treatment of Sleep Disturbance
John W. Winkelman, MD, PhD
Effective Use of Stimulants in Psychiatry – Adult ADD, Anti-Depressant Augmentation, and Eating Disorders
John Ratey, MD
Child and Adolescent Psychopharmacology – Current and Recent Pharmacologic Treatments
Barbara J. Coffey, MD, MS
Panel Discussion
Moderator – Carl Salzman, MD
Panel – Drs. Winkelman, Sheehan, Ratey, and Coffe
Pharmacological Treatment of Substance Use Disorders – Opioids, Alcohol and Marijuana
Roger D. Weiss, MD
Use of Psychotropic Drugs in the Life Cycle of Women – PMS, Pregnancy, Lactation and Menopause
Ariadna Forray, MD
Geriatric Psychopharmacology – What Every Prescriber Should Know About Treating the Elderly with Medications
Carl Salzman, MD
Panel Discussion
Moderator – Carl Salzman, MD
Panel – Drs. Forray and Weiss

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.